Dermaceutic

Dermaceutic is a French dermocosmetics company founded in 2002, specialising in professional-grade skincare and chemical peels distributed mainly through dermatologists, aesthetic physicians and skin clinics rather than ordinary retail [1]. The laboratory describes itself as having been born from a collaboration between French dermatologists, built on the conviction that "science is the natural ally of skin." Its products are developed and manufactured in France, and the company says it works with more than 30,000 skin specialists across some 80 countries [1].

The brand is positioned at the clinical end of the skincare market. Alongside consumer-facing cosmeceuticals, it produces professional chemical peels registered as Class IIa medical devices, which are sold for use only by qualified practitioners such as dermatologists, aesthetic physicians and skin therapists [6]. According to the company, it was the first chemical-peeling laboratory in France, and it describes itself as one of the first laboratories to introduce active ingredients such as hyaluronic acid, stabilised vitamin C and glycolic acid into this category [1].

Dermaceutic dates its founding to 2002. The company frames its origins as a collaboration with French dermatologists, centred on the idea that the skin possesses its own regenerative capacity and that science exists to support it. From the outset the laboratory positioned itself around chemical peels, a treatment then more established in clinical dermatology than in everyday skincare, and it describes itself as the market leader in medical chemical peeling in France since that founding [6].

The company's stated philosophy is summarised under the name "Skintelligent Science," which it presents as an approach to putting recent scientific knowledge in the service of skincare. It frames this around three strands: the study of skin itself, including its composition, physiology and microbiome; the needs of skin professionals and their patients; and the formulation work of dosing and combining active ingredients for tolerance and efficacy. Dermaceutic states that its mission is to "advance the field of aesthetic dermatology through scientific rigor, ethical practices and a patient-centered approach," and lists integrity, innovation, respect for patient needs, humility and curiosity among its values. Its French tagline, "La science exacte appliquée à la peau," translates as "exact science applied to skin."

The brand's audience is largely defined by skin concerns rather than demographics: it markets formulas for ageing, pigmentation, acne, dehydration and sensitivity, typically accessed through clinics and skin specialists [7].

Dermaceutic's range spans professional peels, cosmeceuticals and so-called "cliniceuticals," together with cleansers, day and night creams, eye care, serums and sunscreen. Among the products identified by third-party coverage are the Tri Vita C30 vitamin C serum, the K Ceutic and Hyal Ceutic post-treatment creams, and an Advanced Cleanser [7]. Hero ingredients cited by the company include hyaluronic acid, stabilised vitamin C, glycolic acid, salicylic acid, niacinamide, retinol, peptides and aloe vera [1].

The company says new products are tested before launch with its key opinion leaders — the dermatologists and skin specialists it works with — on the intended population to gauge feasibility and effectiveness [4]. It describes its formulas as combining a high number of active ingredients at measured concentrations, and states that products are clinically tested under dermatological control [6].

Dermaceutic publishes a corporate social responsibility programme covering its formulation, packaging and sourcing. The company states that all of its products are developed and manufactured in France and that its formulas exclude controversial ingredients and endocrine disruptors. On packaging, it reports reducing secondary cardboard by an average of 24% across its cosmeceutical range in 2020, moving its primary packaging to single-material PE to simplify recycling, and replacing paper inserts with QR-code-based digital instructions in 2022 [5]. It also describes a set of forward-looking goals for 2025–2027, including a redesign of its medical-device packaging and a revised sample-distribution strategy.

The UK skincare retailer and editorial site dermoi profiled Dermaceutic in 2024, describing it as "a pioneering French skincare brand celebrated for its advanced chemical peels and scientifically formulated skincare products" and as "France's leading medical-grade chemical peel brand" [7].

Dermaceutic is an active company. It operates a live e-commerce site, maintains professional partnerships across roughly 80 countries, runs active social media channels, and has published a CSR roadmap extending through 2027, all consistent with ongoing operations [5].